Professor | Xiaomeng Dai | Asia Growth Partners

	Upload Avatar (500 x 500)
Name	Xiaomeng Dai
Contact Information	dxm1106@zju.edu.cn
Language ability	Chinese, English
Province	Zhejiang

Upload Avatar (500 x 500)

Name

Xiaomeng Dai

Contact Information

dxm1106@zju.edu.cn

Language ability

Chinese, English

Province

Zhejiang

University/Lab Affiliation and Title	Zhejiang University
Faculty	Medical
Academic Background & Achievements	Master's Supervisor at Zhejiang University Distinguished Researcher at the First Affiliated Hospital of Zhejiang University Currently leading one National Natural Science Foundation Youth Project and one Zhejiang Provincial Natural Science Foundation Youth Project Editorial board member of Exploration Youth Reviewer for Journal for ImmunoTherapy of Cancer, Research, Cellular Signalling Published SCI articles with total citations > 1000, H-index 18

University/Lab Affiliation and Title

Zhejiang University

Faculty

Medical

Academic Background & Achievements

Master's Supervisor at Zhejiang University
Distinguished Researcher at the First Affiliated Hospital of Zhejiang University
Currently leading one National Natural Science Foundation Youth Project and one Zhejiang Provincial Natural Science Foundation Youth Project
Editorial board member of Exploration Youth
Reviewer for Journal for ImmunoTherapy of Cancer, Research, Cellular Signalling
Published SCI articles with total citations > 1000, H-index 18

Areas of Focus	Targeting Tumor-Associated Macrophages: Basic and Translational Research Drug Delivery Systems and Immunotherapy
Publications	A multiomics analysis-assisted deep learning model identifies a macrophage-oriented module as a potential therapeutic target in colorectal cancer, Bao XW+, Li Q+, Chen D+, Dai XM+, et al., 2024 Nano-enhanced immunotherapy: Targeting the immunosuppressive tumor microenvironment, Jin YZ+, Huang YY+, Ren H+, …Zhao P* & Dai XM, 2024 Induction of Tumor Ferroptosis-Dependent Immunity via an Injectable Attractive Pickering Emulsion Gel, Dai XM+, J Zhang+, XW Bao+, et al., 2023 An immunometabolism subtyping system identifies S100A9+ macrophage as an immune therapeutic target in colorectal cancer based on multiomics analysis, Bao XW+, Wang DY+, Dai XM+, et al., 2023 Immunotherapy for targeting cancer stem cells in hepatocellular carcinoma, Dai XM+, Guo YX+, Hu Y, et al., 2021 Enhanced radiotherapy efficacy and induced anti-tumor immunity in HCC by improving hypoxia microenvironment using oxygen microcapsules, Dai XM+, Ruan J+; Guo YX+, et al., 2021 Targeting CAMKII to reprogram tumor- associated macrophages and inhibit tumor cells for cancer immunotherapy with an injectable hybrid peptide hydrogel, Dai XM+, Meng JS+, Deng SK+, et al., 2020 USP7 targeting modulates anti-tumor immune response by reprogramming Tumor-associated Macrophages in Lung Cancer, Dai XM+, Lu LS+, Deng SK, et al., 2020 Association of PD-L1 and HIF-1 alpha Coexpression with Poor Prognosis in Hepatocellular Carcinoma, Dai XM+, Pi GL+, Yang SL*, et al., 2018 Positive Expression of Programmed Death Ligand 1 in Peritumoral Liver Tissue is Associated with Poor Survival after Curative Resection of Hepatocellular Carcinoma, Dai XM+, Xue J+, Hu JL, et al., 2017

Areas of Focus

Targeting Tumor-Associated Macrophages: Basic and Translational Research
Drug Delivery Systems and Immunotherapy

Publications

A multiomics analysis-assisted deep learning model identifies a macrophage-oriented module as a potential therapeutic target in colorectal cancer, Bao XW+, Li Q+, Chen D+, Dai XM+, et al., 2024
Nano-enhanced immunotherapy: Targeting the immunosuppressive tumor microenvironment, Jin YZ+, Huang YY+, Ren H+, …Zhao P* & Dai XM*, 2024
Induction of Tumor Ferroptosis-Dependent Immunity via an Injectable Attractive Pickering Emulsion Gel, Dai XM+*, J Zhang+, XW Bao+, et al., 2023
An immunometabolism subtyping system identifies S100A9+ macrophage as an immune therapeutic target in colorectal cancer based on multiomics analysis, Bao XW+, Wang DY+, Dai XM+, et al., 2023
Immunotherapy for targeting cancer stem cells in hepatocellular carcinoma, Dai XM+, Guo YX+, Hu Y, et al., 2021
Enhanced radiotherapy efficacy and induced anti-tumor immunity in HCC by improving hypoxia microenvironment using oxygen microcapsules, Dai XM+, Ruan J+; Guo YX+, et al., 2021
Targeting CAMKII to reprogram tumor- associated macrophages and inhibit tumor cells for cancer immunotherapy with an injectable hybrid peptide hydrogel, Dai XM+, Meng JS+, Deng SK+, et al., 2020
USP7 targeting modulates anti-tumor immune response by reprogramming Tumor-associated Macrophages in Lung Cancer, Dai XM+, Lu LS+, Deng SK, et al., 2020
Association of PD-L1 and HIF-1 alpha Coexpression with Poor Prognosis in Hepatocellular Carcinoma, Dai XM+, Pi GL+, Yang SL*, et al., 2018
Positive Expression of Programmed Death Ligand 1 in Peritumoral Liver Tissue is Associated with Poor Survival after Curative Resection of Hepatocellular Carcinoma, Dai XM+, Xue J+, Hu JL, et al., 2017

Tumor Macrophages Translational Research Drug Delivery Immunotherapy Single Cell Immune Activation Cancer Therapeutic Target Multiomics

Linrong Lu - Zhejiang University

Qingqing Wang - Zhejiang University

Jimin Shao - Zhejiang University

View All

Personal Information

Academic Information

Research

Contact us

No account yet?

Personal Information

Academic Information

Research

Contact us